Anxiety, Depression Remain High Following Initial Lockdown
Jagdish Khubchandani, M.B.B.S., Ph.D., from New Mexico State University in Las Cruces, and colleagues conducted a survey to assess the prevalence of depression and anxiety in the adult U.S. population after initial COVID-19 lockdowns.
The researchers found that the prevalence of depression was 39 percent, anxiety was 42 percent, and psychological distress was 39 percent. Depression was more likely among men, while anxiety was more likely among women. Depression was significantly higher for Hispanics, while anxiety prevalence was high among African-Americans and Hispanics. The prevalence rates of all three conditions were high among married individuals, those with children at home, bachelor's degree holders, those employed full time, health care workers, and those earning less than $60,000. Depression and anxiety prevalence were high among those ages 18 to 25 years, while the prevalence of moderate-to-severe psychological distress was high for those ages 18 to 40 years.
"Our study results indicate that the rate of serious mental health issues such as depression and anxiety have more than doubled in the USA during the pandemic (i.e., compared to the rates before the pandemic in the year 2019)," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, March 5, 2021 -- Psychiatric visits increased significantly during 2020 compared with 2019, but there was a decrease in new patients seeking care, according to a study...
WEDNESDAY, March 3, 2021 -- Self-reported symptoms of behavioral health issues remain high as the COVID-19 pandemic continues, according to a research letter published online Feb....
WEDNESDAY, March 3, 2021 -- Discordance between patient and physician assessments of psoriasis severity is associated with patient depression and anxiety, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.